Vaccination against COVID19 in India : yay or nay
Not Applicable
Completed
- Registration Number
- CTRI/2021/08/035422
- Lead Sponsor
- VMMC and Safdarjung Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1096
Inclusion Criteria
Healthcare workers in India who have received covaxin or covishield vaccine
who are willing to participate in the survey
who understand english
Exclusion Criteria
HCWs who are not vaccinated with covaxin or covishield
who are not willing to participate
who do not understand english
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To estimate the incidence of COVID infection after vaccination in Health Care Workers in India <br/ ><br>2.To estimate the incidence of severe infections amongst those HCWs infected after vaccination <br/ ><br>3.To estimate hospitalisation required in severe COVID infections in HCWs after vaccinations <br/ ><br>4.To compare rate of infections between those HCWs vaccinated with Covaxin vs Covishield <br/ ><br> <br/ ><br>Timepoint: All the values will be calculated at baseline (after data collection). No follow up will be done.
- Secondary Outcome Measures
Name Time Method 1. Correlation of covid infection post vaccination with comorbidity <br/ ><br>2. Oxygen requirement in case of COVID infection post vaccination <br/ ><br>3. Risk factors like place of work, wearing PPE etc at time of infectionTimepoint: The values will be calculated in terms of percentage after data collection. There will be no follow up.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie breakthrough SARS-CoV-2 infections in CTRI/2021/08/035422 vaccinated healthcare workers?
How do Covishield and Covaxin compare in preventing breakthrough infections among CTRI/2021/08/035422 participants?
Which biomarkers predict vaccine efficacy in CTRI/2021/08/035422 post-vaccination SARS-CoV-2 infections?
What adverse events were reported in CTRI/2021/08/035422 and how do they compare to standard-of-care vaccines in India?
How does CTRI/2021/08/035422 data inform the role of booster doses in mitigating viral variants among healthcare workers?